In March 2025, the company introduced new ideas for a immediate-to-purchaser providing of its Wegovy weight loss drug. The company recognized a brand new pharmacy, referred to as NovoCare, which might charge customers $499 per month for usage of the drug, less than 50 % the price of the drug by way of other pharmaceutical distribution networks.[fif

copyright has created headlines in past times several months for not just the shortage but certainly one of the principal will cause with the stated scarcity. The drug is intended for individuals with Form 2 diabetes, and it is a after-a-week injection.Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd,[thr